KCM
Kynam Capital Management Portfolio holdings
AUM
$929M
This Quarter Return
+20.07%
1 Year Return
-7.66%
3 Year Return
+163.82%
5 Year Return
–
10 Year Return
–
AUM
$473M
AUM Growth
+$473M
(+22%)
Cap. Flow
-$59.3M
Cap. Flow
% of AUM
-12.52%
Top 10 Holdings %
Top 10 Hldgs %
73.64%
Holding
39
New
4
Increased
11
Reduced
17
Closed
2
Top Buys
| 1 |
Natera
NTRA
|
$34.1M |
| 2 |
United Therapeutics
UTHR
|
$31.6M |
| 3 |
Sanofi
SNY
|
$22.8M |
| 4 |
GSK
GSK
|
$14.7M |
| 5 |
Celldex Therapeutics
CLDX
|
$13.2M |
Top Sells
| 1 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$141M |
| 2 |
Gossamer Bio
GOSS
|
$23.5M |
| 3 |
Travere Therapeutics
TVTX
|
$20.2M |
| 4 |
BioCryst Pharmaceuticals
BCRX
|
$6.32M |
| 5 |
Syndax Pharmaceuticals
SNDX
|
$5.75M |
Sector Composition
| 1 | Healthcare | 97.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Natera
NTRA
$23.1B
| $88.4M | 18.64% |
2,018,360
+779,313
| +63% | +$34.1M |
|
|
2
Syndax Pharmaceuticals
SNDX
$1.41B
| $54.6M | 11.51% |
2,272,915
-239,325
| -10% | -$5.75M |
|
|
3
Celldex Therapeutics
CLDX
$1.47B
| $45M | 9.48% |
1,600,127
+467,868
| +41% | +$13.2M |
|
4
Vera Therapeutics
VERA
$1.38B
| $32.7M | 6.9% |
1,536,181
+13,469
| +0.9% | +$287K |
|
|
5
United Therapeutics
UTHR
$13.8B
| $31.6M | 6.66% |
+151,009
| New | +$31.6M |
|
|
6
Sanofi
SNY
$121B
| $22.8M | 4.81% |
+600,000
| New | +$22.8M |
|
7
Viridian Therapeutics
VRDN
$1.5B
| $20.5M | 4.32% |
1,000,000
+409,857
| +69% | +$8.41M |
|
8
Biogen
BIIB
$19.4B
| $20M | 4.22% |
75,000
-3,951
| -5% | -$1.05M |
|
9
Vaxcyte
PCVX
$4B
| $16.8M | 3.53% |
698,638
-25,143
| -3% | -$603K |
|
|
BNR
10
Burning Rock Biotech
BNR
$93.6M
| $16M | 3.38% |
6,703,863
+2,403,863
| +56% | +$5.75M |
|
|
11
GSK
GSK
$79.9B
| $14.7M | 3.1% |
+500,000
| New | +$14.7M |
|
12
Cogent Biosciences
COGT
$1.69B
| $14.7M | 3.1% |
985,155
-14,845
| -1% | -$221K |
|
|
CNCE
13
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $11.2M | 2.36% |
1,673,041
+673,041
| +67% | +$4.51M |
|
|
14
Travere Therapeutics
TVTX
$1.56B
| $10.3M | 2.16% |
416,729
-818,422
| -66% | -$20.2M |
|
15
Liquidia Corp
LQDA
$2.38B
| $9.21M | 1.94% |
1,692,402
+191,684
| +13% | +$1.04M |
|
|
GBT
16
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $8.94M | 1.88% |
131,220
-2,068,780
| -94% | -$141M |
|
|
AMRN
17
Amarin Corp
AMRN
$311M
| $7.33M | 1.54% |
6,720,148
+2,710,255
| +68% | +$2.95M |
|
18
Amicus Therapeutics
FOLD
$2.34B
| $7.07M | 1.49% |
676,849
-223,151
| -25% | -$2.33M |
|
|
19
BioCryst Pharmaceuticals
BCRX
$1.74B
| $5.48M | 1.16% |
435,117
-501,446
| -54% | -$6.32M |
|
20
Wave Life Sciences
WVE
$1.53B
| $5.05M | 1.06% |
1,397,479
-299,256
| -18% | -$1.08M |
|
21
Seres Therapeutics
MCRB
$166M
| $4.96M | 1.05% |
772,820
+514,173
| +199% | +$3.3M |
|
|
AKUS
22
DELISTED
Akouos, Inc. Common Stock
AKUS
| $4.86M | 1.02% |
718,394
+334,610
| +87% | +$2.26M |
|
|
23
Gossamer Bio
GOSS
$562M
| $4.63M | 0.98% |
386,349
-1,964,099
| -84% | -$23.5M |
|
24
Protagonist Therapeutics
PTGX
$3.67B
| $4.38M | 0.92% |
+519,212
| New | +$4.38M |
|
25
Olema Pharmaceuticals
OLMA
$375M
| $3.86M | 0.81% |
1,399,633
+1,150,404
| +462% | +$3.18M |
|